Publications by authors named "D Lukac"

PARP inhibitors (PARPi), known for their ability to induce replication gaps and accelerate replication forks, have become potent agents in anticancer therapy. However, the molecular mechanism underlying PARPi-induced fork acceleration has remained elusive. Here, we show that the first PARPi-induced effect on DNA replication is an increased replication fork rate, followed by a secondary reduction in origin activity.

View Article and Find Full Text PDF

Unlabelled: The cellular Notch signal transduction pathway is intimately associated with infections by Kaposi's sarcoma-associated herpesvirus (KSHV) and other gamma-herpesviruses. RBP-Jk, the cellular DNA binding component of the canonical Notch pathway, is the key Notch downstream effector protein in virus-infected and uninfected animal cells. Reactivation of KSHV from latency requires the viral lytic switch protein, Rta, to form complexes with RBP-Jk on numerous sites within the viral DNA.

View Article and Find Full Text PDF
Article Synopsis
  • Cannabidiol (CBD) is a marijuana derivative recognized for its long history of medical use and is gaining attention for its potential anti-tumor properties in cancer treatment.
  • Research suggests that CBD may not only help reduce side effects of chemotherapy but also enhance the effectiveness of certain anticancer drugs.
  • The review highlights the need for more clinical trials and research to understand the interactions between CBD and traditional cancer therapies, as well as the associated benefits and risks of combined treatments.
View Article and Find Full Text PDF